MENU
NRXP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
NRX Pharmaceuticals (NRXP) Ownership - Who owns NRX Pharmaceuticals?
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases... Show more
Profile
Industry
N/A
Address
1201 Orange Street
Phone
+1 484 254-6134
Employees
N/A
Web
https://nrxpharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
34M
P/E Ratio
0.36
Total Cash
1.44M
Projected Growth
N/A
Total Debt
6.58M
Revenue
N/A
Risk (Beta)
1.57
Dividend Yield
N/A
Total Cash/Share
0.09
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
NRXP
Capitalization
34M
P/E Ratio
0.36
Risk (Beta)
1.57
Dividend Yield
N/A
Total Cash
1.44M
Total Cash/Share
0.09
Total Debt
6.58M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-23.22M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-2.36
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
15K
Current Ratio
0.15
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-24.89M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-458.25
Shares Held By Institutions
2.91M
Shares Outstanding - Current
16.9M
Total Liabilities
26.9M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-8.636
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
is a blank check company, which engages in a stock exchange, asset acquisition, stock purchase, and reorganization
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
1201 Orange Street
Phone
+1 484 254-6134
Employees
N/A
Web
https://nrxpharma.com